IL-6 is overexpressed in CRC patients and is correlated with a larger tumor size, the occurrence of liver metastasis and reduced survival rates, as this interleukin is also a potent stimulator of colon cancer cell proliferation [53,54,55]. Here, IL6 is linked to neoplasm.